Neurocrine’s ingrezza shows efficacy in tardive dyskinesia study
Neurocrine (NBIX) presented new data from the long-term, open-label KINECT 4 study demonstrating remission of tardive dyskinesia among the ...
Neurocrine presents new KINECT-HD data
Biosciences presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with ...